Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albigès, Fabrice Barlési, Frank Griscelli et al.|Nature Cancer|2020Cited by 119
20MO Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician’s choice (TPC)Domenica Lorusso, V. Makker, N. Colombo et al.|Annals of Oncology|2022Cited by 1
Disparity in oncology therapy access and differences in clinical pathological features and outcomes in indigenous population lung cancer (LC): A retrospective study from Martinique.Marlyne Moranton, Moustapha Agossou, Émeline Colomba et al.|Journal of Clinical Oncology|2024Cited by 1
High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West IndiesRégine Marlin, Moustapha Agossou, Émeline Colomba et al.|Frontiers in Oncology|2026Cited by 0